Terms: = Colorectal cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
7 results:
1. Systemic Inflammation Associates With a Myeloid Inflamed Tumor Microenvironment in Primary Resected Colon cancer-May Cold Tumors Simply Be Too Hot?
Køstner AH; Nielsen PS; Georgsen JB; Parner ET; Nielsen MB; Kersten C; Steiniche T
Front Immunol; 2021; 12():716342. PubMed ID: 34531864
[TBL] [Abstract] [Full Text] [Related]
2. A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis.
Kim SY; Baek JY; Oh JH; Park SC; Sohn DK; Kim MJ; Chang HJ; Kong SY; Kim DY
Radiat Oncol; 2017 Mar; 12(1):62. PubMed ID: 28347333
[TBL] [Abstract] [Full Text] [Related]
3. Two SNPs of ATP-binding cassette B1 gene on the risk and prognosis of colorectal cancer.
Wang F; Huang Z; Zheng K; Zhao H; Hu W
Int J Clin Exp Pathol; 2015; 8(3):3083-9. PubMed ID: 26045821
[TBL] [Abstract] [Full Text] [Related]
4. HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.
Feng Y; Xu X; Zhang Y; Ding J; Wang Y; Zhang X; Wu Z; Kang L; Liang Y; Zhou L; Song S; Zhao K; Ye Q
Sci Rep; 2015 Mar; 5():9429. PubMed ID: 25800793
[TBL] [Abstract] [Full Text] [Related]
5. B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer.
Meshcheryakova A; Tamandl D; Bajna E; Stift J; Mittlboeck M; Svoboda M; Heiden D; Stremitzer S; Jensen-Jarolim E; Grünberger T; Bergmann M; Mechtcheriakova D
PLoS One; 2014; 9(6):e99008. PubMed ID: 24905750
[TBL] [Abstract] [Full Text] [Related]
6. Immunological effects of bevacizumab-based treatment in metastatic colorectal cancer.
Manzoni M; Rovati B; Ronzoni M; Loupakis F; Mariucci S; Ricci V; Gattoni E; Salvatore L; Tinelli C; Villa E; Danova M
Oncology; 2010; 79(3-4):187-96. PubMed ID: 21358206
[TBL] [Abstract] [Full Text] [Related]
7. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
Zlobec I; Lugli A
World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
[TBL] [Abstract] [Full Text] [Related]
